Optieum Biotechnologies ^None

Optieum Biotechnologies Inc. is a biotechnology company focused on developing scFv antibody-based therapies for cancer treatment. Their Eumbody System technology helps in developing and detecting scFv-based product candidates that bind to and optimize immune-cell function for oncology targets. The company aims to create optimized scFvs that can yield CAR-T cells with strong anti-tumor effects to help patients with severe diseases.